Rejected
at 12:39 a.m. Jan, 21, 2025 ]
by
andrewmathias8
Author:
ccahn95918
Type of change:
Content error
Rationale for change
Your AI contradicted this card when asked. The card should read cilostazol, not clopidogrel.
Rejection reason
The card is worded poorly, but is technically correct. Antiplatelet therapy (aspirin or clopidogrel) is indicated for all patients with PAD to decrease progression and/or complications, while cilostazol is used to manage *symptoms* stemming from persistent claudication (e.g., numbness). We will submit a different suggestion to improve the wording. Thank you!
Current
Suggested
Text
Text
Text
Text
Extra
- Antiplatelet therapy (aspirin or clopidogrel) is indicated for all patients with PAD to decrease progression and/or complications, including MI or stroke
- Cilostazol is used to manage symptoms of persistent claudication despite first-line options (exercise therapy and risk factor modification)
- This card previously asked for a single most appropriate medication for PAD management but has been updated to distinguish between prevention and symptom management (Feb 2025)
- Cilostazol is used to manage symptoms of persistent claudication despite first-line options (exercise therapy and risk factor modification)
- This card previously asked for a single most appropriate medication for PAD management but has been updated to distinguish between prevention and symptom management (Feb 2025)
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Peripheral Venous and Arterial Disease: Peripheral Artery Disease
OME
Additional Resources
Empty field
One by one
Empty field



